Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Diagnostic Developments

    This is a preview of subscription content, log in to check access.

    Table I

    Notes

    1. 1.

      Epigenomics and its collaboration with Roche was profiled in Pharmaceutical & Diagnostic Innovation 2004; 5 (2): 51–5.

    2. 2.

      The study was published in the Journal of Clinical Oncology 2006; 24 (2): 252–8.

    3. 3.

      Conformite Europeene.

    References

    1. 1.

      Epigenomics. Epigenomics successfully completes biomarker validation study for prostate cancer classification test. Media release: 4 Jan 2006

    2. 2.

      European Biotechnology. Epigenomics AG: change of price target. New York: Lehman Brothers Global Equity Research, 2005

    3. 3.

      Epigenomics. Epigenomics DNA methylation test successfully detects colorectal cancer in blood. Media release: 19 Dec 2005

    4. 4.

      Iceland Genomics. EU consortium POLYGENE led by Iceland Genomics Corporation Receives a 3M € grant from the 6th Framework Programme to study inherited risk of breast and prostate cancer. Media release: 19 Dec 2005

    5. 5.

      Immunomedics. New diagnostic assay for pancreatic cancer reported in Journal of Clinical Oncology. Media release: 16 Dec 2005

    6. 6.

      MedMira. MedMira receives CE Mark for MiraCare Rapid HIV Test; Europeans now have access to first instant rapid HIV test. Media release: 17 Jan 2006

    7. 7.

      MedMira. MedMira granted hepatitis C patent in Europe; Patent further protects MedMira’s diagnostic technology. Media release: 3 Jan 2006

    8. 8.

      CeMines. CeMines® granted European Union regulatory clearance and CE Mark registration of its Cell Correct LAb® clinical Dx test for lung cancer. Media release: 11 Jan 2006

    9. 9.

      Tm Bioscience. Tm Bioscience cystic fibrosis test now has CE mark. Media release: 11 Jan 2006

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Diagnostic Developments. Pharmaceutical & Diagnostic Innovation 4, 16–18 (2006). https://doi.org/10.1007/BF03257034

    Download citation